FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Time-Cap Laboratories Ibuprofen Tablets Recall

Ibuprofen Tablets, USP 600 mg, 500-count bottle (Capsule Shaped), Rx only, Manufactured…

Time-Cap Laboratories, Inc. · Farmingdale, NY

Risk level
Class II
Reported by FDA
Aug 9, 2017
Recall ID
D-1055-2017
Check your lot numberHow we source this data

Summary

Time-Cap Laboratories recalled Ibuprofen Tablets starting Jun 16, 2017. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1055-2017 on Aug 9, 2017. Reason: Presence of foreign tablets/capsules: Ibuprofen Tablets USP, 600 mg bottles were found to contain some Ibuprofen Tablets USP 800 mg. Status: Terminated.

Why it was recalled

Presence of foreign tablets/capsules: Ibuprofen Tablets USP, 600 mg bottles were found to contain some Ibuprofen Tablets USP 800 mg.

Product description

Ibuprofen Tablets, USP 600 mg, 500-count bottle (Capsule Shaped), Rx only, Manufactured for: Time Cap Labs, Inc., 7 Michael Avenue Farmingdale, NJ 11735, USA, Manufactured by: Marksans Pharma Ltd. Plot No. L-82, L-83 Verna Indl. Estate, Verna, Goa-403 722, India, NDC 49483-603-50

Lot numbers, UPCs & expiration codes

Lot #: HN7003

Where it was sold

Nationwide U.S.A.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1055-2017
Classification
Class II
Status
Terminated
Recall initiated
Jun 16, 2017
FDA report date
Aug 9, 2017
Quantity
1,980 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Time-Cap Laboratories, Inc.

Original FDA data

Every field from FDA enforcement report D-1055-2017, exactly as published.

Show all FDA fields
City
Farmingdale
State
NY
Status
Terminated
Country
United States
Event ID
77576
Address
7 Michael Ave
Code information
Lot #: HN7003
Postal code
11735-3921
Report date
Aug 9, 2017
Product type
Drugs
Recall number
D-1055-2017
Classification
Class II
Recalling firm
Time-Cap Laboratories, Inc.
Product quantity
1,980 bottles
Termination date
May 29, 2020
Reason for recall
Presence of foreign tablets/capsules: Ibuprofen Tablets USP, 600 mg bottles were found to contain some Ibuprofen Tablets USP 800 mg.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Ibuprofen Tablets, USP 600 mg, 500-count bottle (Capsule Shaped), Rx only, Manufactured for: Time Cap Labs, Inc., 7 Michael Avenue Farmingdale, NJ 11735, USA, Manufactured by: Marksans Pharma Ltd. Plot No. L-82, L-83 Verna Indl. Estate, Verna, Goa-403 722, India, NDC 49483-603-50
Distribution pattern
Nationwide U.S.A.
Recall initiation date
Jun 16, 2017
Initial firm notification
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Center classification date
Aug 3, 2017

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1055-2017, published Aug 9, 2017. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls